In the last 12 months, insiders at Applied Therapeutics, Inc. ($APLT) filed 86 transactions with the SEC: 0 open-market purchases totaling $0 and 21 sales totaling $9,458,228. Net insider sentiment: net selling.
Applied Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Shendelman Shoshana (President and CEO) — 7 transactions totaling $6,696,112
- ALEXANDRIA REAL ESTATE EQUITIES, INC. (TenPercentOwner) — 2 transactions totaling $1,267,500
- Perfetti Riccardo (Chief Medical Officer) — 5 transactions totaling $881,585
- Funtleyder Leslie D. (Chief Financial Officer) — 16 transactions totaling $307,072
- Hansard Adam (Chief Commercial Officer) — 1 transaction totaling $263,415
View all SEC Filings for Applied Therapeutics, Inc. (APLT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Common Stock | 22500 | $0.00 | 42,500.0000 | 145,559,604 | 34.62% | 0.02% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.14% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Stock Option (Right to Buy) | 10230 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | D | Stock Option (Right to Buy) | 20460 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Kanter Stacy J. | Not found | U | Common Stock | 42500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.03% |
| Feb. 3, 2026 | Lerner Teena | Not found | U | Common Stock | 82922 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.06% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Common Stock | 22500 | $0.00 | 82,922.0000 | 145,559,604 | 21.34% | 0.02% |
| Feb. 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | D | Stock Option (Right to Buy) | 4883 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.00% |
| Feb. 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | D | Stock Option (Right to Buy) | 19531 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | U | Common Stock | 60901 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.04% |
| Feb. 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | D | Common Stock | 1235915 | $0.00 | 60,901.0000 | 145,559,604 | 95.30% | 0.85% |
| Dec. 19, 2025 | Bailey Evan Prescott | Chief Medical Officer | A | Common Stock | 437500 | $0.00 | 1,296,816.0000 | 145,559,604 | 50.91% | 0.30% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 40502 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.03% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.10% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 10230 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 20460 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | U | Common Stock | 152959 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.11% |
| Feb. 3, 2026 | Funtleyder Leslie D. | Chief Financial Officer | D | Common Stock | 2375000 | $0.00 | 152,959.0000 | 145,559,604 | 93.95% | 1.63% |
| Dec. 19, 2025 | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 1187500 | $0.00 | 2,527,959.0000 | 145,559,604 | 88.59% | 0.82% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.14% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Stock Option (Right to Buy) | 10230 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Stock Option (Right to Buy) | 20460 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | U | Common Stock | 42500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.03% |
| Feb. 3, 2026 | SKYLER JAY S | Not found | D | Common Stock | 22500 | $0.00 | 42,500.0000 | 145,559,604 | 34.62% | 0.02% |
| Feb. 3, 2026 | Chinoporos Constantine | See Remarks | U | Common Stock | 57111 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.04% |
| Feb. 3, 2026 | Chinoporos Constantine | See Remarks | D | Common Stock | 1000000 | $0.00 | 57,111.0000 | 145,559,604 | 94.60% | 0.69% |
| Dec. 19, 2025 | Chinoporos Constantine | See Remarks | A | Common Stock | 437500 | $0.00 | 1,057,111.0000 | 145,559,604 | 70.61% | 0.30% |
| Feb. 3, 2026 | Hooks Corwin Dale | Chief Commercial Officer | U | Common Stock | 5753 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.00% |
| Dec. 19, 2025 | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 312500 | $0.00 | 868,253.0000 | 145,559,604 | 56.23% | 0.21% |
| Feb. 3, 2026 | Hooks Corwin Dale | Chief Commercial Officer | D | Common Stock | 862500 | $0.00 | 5,753.0000 | 145,559,604 | 99.34% | 0.59% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 23941 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.02% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.14% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 10230 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Lerner Teena | Not found | D | Stock Option (Right to Buy) | 20460 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Jan. 1, 2026 | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 1,340,459.0000 | 145,559,604 | 12.60% | 0.10% |
| Dec. 16, 2025 | Kanter Stacy J. | Not found | S | Common Stock | 43000 | $0.11 | 65,000.0000 | 145,559,604 | 39.81% | 0.03% |
| Oct. 1, 2025 | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 1,190,459.0000 | 145,559,604 | 14.42% | 0.10% |
| June 9, 2025 | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 787,121.0000 | 139,534,746 | 23.54% | 0.11% |
| July 1, 2025 | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 937,121.0000 | 139,534,746 | 19.06% | 0.11% |
| June 15, 2025 | Bailey Evan Prescott | Chief Medical Officer | A | Common Stock | 300000 | $0.00 | 841,669.0000 | 139,534,746 | 55.38% | 0.22% |
| June 9, 2025 | Lerner Teena | Not found | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 139,534,746 | 9999.99% | 0.14% |
| June 9, 2025 | Kanter Stacy J. | Not found | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 139,534,746 | 9999.99% | 0.14% |
| June 9, 2025 | SKYLER JAY S | Not found | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 139,534,746 | 9999.99% | 0.14% |
| March 24, 2025 | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 250000 | $0.00 | 550,000.0000 | 139,534,746 | 83.33% | 0.18% |
| March 24, 2025 | Funtleyder Leslie D. | See Remarks | A | Common Stock | 350000 | $0.00 | 740,459.0000 | 139,534,746 | 89.64% | 0.25% |
| March 24, 2025 | Chinoporos Constantine | See Remarks | A | Common Stock | 350000 | $0.00 | 621,436.0000 | 139,534,746 | 128.94% | 0.25% |
| March 4, 2025 | Perfetti Riccardo | Chief Medical Officer | S | Common Stock | 10366 | $0.44 | 890,409.0000 | 139,534,746 | 1.15% | 0.01% |
| March 4, 2025 | Funtleyder Leslie D. | See Remarks | S | Common Stock | 14502 | $0.44 | 390,459.0000 | 139,534,746 | 3.58% | 0.01% |
| March 4, 2025 | Chinoporos Constantine | See Remarks | S | Common Stock | 447 | $0.44 | 271,436.0000 | 139,534,746 | 0.16% | 0.00% |
| Feb. 6, 2025 | Perfetti Riccardo | Chief Medical Officer | S | Common Stock | 86078 | $0.61 | 900,775.0000 | 139,534,746 | 8.72% | 0.06% |
| Feb. 6, 2025 | Chinoporos Constantine | See Remarks | S | Common Stock | 28117 | $0.61 | 271,883.0000 | 139,534,746 | 9.37% | 0.02% |
| Feb. 6, 2025 | Funtleyder Leslie D. | See Remarks | S | Common Stock | 22950 | $0.61 | 404,961.0000 | 139,534,746 | 5.36% | 0.02% |
| Dec. 19, 2024 | Funtleyder Leslie D. | See Remarks | A | Common Stock | 150000 | $0.00 | 427,911.0000 | 144,345,781 | 53.97% | 0.10% |
| Dec. 19, 2024 | JOHNSON JOHN | Executive Chairman | A | Common Stock | 500000 | $0.00 | 500,000.0000 | 144,345,781 | 9999.99% | 0.35% |
| Dec. 19, 2024 | Funtleyder Leslie D. | See Remarks | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 144,345,781 | 9999.99% | 0.10% |
| Dec. 19, 2024 | JOHNSON JOHN | Executive Chairman | A | Stock Option (Right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 144,345,781 | 9999.99% | 0.69% |
| Aug. 22, 2024 | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 13530 | $5.83 | 277,911.0000 | 84,244,494 | 4.64% | 0.02% |
| Aug. 22, 2024 | Perfetti Riccardo | Chief Medical Officer | S | Common Stock | 22681 | $5.83 | 986,853.0000 | 84,244,494 | 2.25% | 0.03% |
| Aug. 5, 2024 | Shendelman Shoshana | President and CEO | G | Common Stock | 747886 | $0.00 | 7,309,496.0000 | 84,244,494 | 11.40% | 0.89% |
| Aug. 14, 2024 | Shendelman Shoshana | President and CEO | S | Common Stock | 119591 | $5.93 | 7,309,496.0000 | 84,244,494 | 1.61% | 0.14% |
| Aug. 13, 2024 | Shendelman Shoshana | President and CEO | S | Common Stock | 357423 | $6.18 | 7,429,087.0000 | 84,244,494 | 4.59% | 0.42% |
| Aug. 12, 2024 | Shendelman Shoshana | President and CEO | S | Common Stock | 300000 | $5.98 | 7,786,510.0000 | 84,244,494 | 3.71% | 0.36% |
| Aug. 5, 2024 | Shendelman Shoshana | President and CEO | G | Common Stock | 747886 | $0.00 | 6,561,610.0000 | 84,244,494 | 10.23% | 0.89% |
| June 6, 2024 | Shendelman Shoshana | President and CEO | S | Common Stock | 61795 | $4.32 | 8,086,510.0000 | 84,244,494 | 0.76% | 0.07% |
| June 6, 2024 | Perfetti Riccardo | Chief Medical Officer | S | Common Stock | 22003 | $4.32 | 1,009,534.0000 | 84,244,494 | 2.13% | 0.03% |
| June 6, 2024 | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 16980 | $4.32 | 291,441.0000 | 84,244,494 | 5.51% | 0.02% |
| June 6, 2024 | Kanter Stacy J. | Not found | A | Common Stock | 45000 | $0.00 | 108,000.0000 | 84,244,494 | 71.43% | 0.05% |
| June 6, 2024 | SKYLER JAY S | Not found | A | Common Stock | 45000 | $0.00 | 65,000.0000 | 84,244,494 | 225.00% | 0.05% |
| June 6, 2024 | MARCUS JOEL S | Not found | A | Common Stock | 45000 | $0.00 | 498,414.0000 | 84,244,494 | 9.92% | 0.05% |
| June 6, 2024 | Lerner Teena | Not found | A | Common Stock | 45000 | $0.00 | 105,422.0000 | 84,244,494 | 74.48% | 0.05% |
| June 4, 2024 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | TenPercentOwner | S | Common Stock | 150000 | $4.21 | 6,209,054.0000 | 84,244,494 | 2.36% | 0.18% |
| June 5, 2024 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | TenPercentOwner | S | Common Stock | 150000 | $4.24 | 6,059,054.0000 | 84,244,494 | 2.42% | 0.18% |
| April 12, 2024 | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 84,244,494 | 9999.99% | 0.36% |
| March 14, 2024 | Shendelman Shoshana | President and CEO | S | Common Stock | 318573 | $5.39 | 8,148,305.0000 | 84,244,494 | 3.76% | 0.38% |
| March 14, 2024 | Perfetti Riccardo | Chief Medical Officer | S | Common Stock | 110804 | $5.39 | 1,031,537.0000 | 84,244,494 | 9.70% | 0.13% |
| March 14, 2024 | Hansard Adam | Chief Commercial Officer | S | Common Stock | 48871 | $5.39 | 732,919.0000 | 84,244,494 | 6.25% | 0.06% |
| March 14, 2024 | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 28727 | $5.39 | 308,421.0000 | 84,244,494 | 8.52% | 0.03% |
| Dec. 28, 2023 | Chinoporos Constantine | See Remarks | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |